nel­jän­nen ­vai­heen k­lii­ni­nen ­ko­e

1. sometimes the FDA approves a drug for general use but requires the manufacturer to continue to monitor its effects; during this phase the drug may be tried on slightly different patient populations than those studied in earlier trials

Synonyymit

Hierarkia